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Translational control of many mRNAs in developing metazoan
embryos is achieved by alterations in their poly(A) tail length. A
family of cytoplasmic poly(A)-binding proteins (PABPs) bind the
poly(A) tail and can regulate mRNA translation and stability. How-
ever, despite the extensive biochemical characterization of one
family member (PABP1), surprisingly little is known about their in
vivo roles or functional relatedness. Because no information is
available in vertebrates, we address their biological roles, estab-
lishing that each of the cytoplasmic PABPs conserved in Xenopus
laevis [PABP1, embryonic PABP (ePABP), and PABP4] is essential for
normal development. Morpholino-mediated knockdown of PABP1
or ePABP causes both anterior and posterior phenotypes and em-
bryonic lethality. In contrast, depletion of PABP4 results mainly in
anterior defects and lethality at later stages. Unexpectedly, cross-
rescue experiments reveal that neither ePABP nor PABP4 can fully
rescue PABP1 depletion, establishing that PABPs have distinct
functions. Comparative analysis of the uncharacterized PABP4
with PABP1 and ePABP shows that it shares a mechanistically con-
served core role in promoting global translation. Consistent with
this analysis, each morphant displays protein synthesis defects,
suggesting that their roles in mRNA-speciﬁc translational regula-
tion and/or mRNA decay, rather than global translation, underlie
the functional differences between PABPs. Domain-swap experi-
ments reveal that the basis of the functional speciﬁcity is complex,
involving multiple domains of PABPs, and is conferred, at least in
part, by protein–protein interactions.
global translational control | mRNA-speciﬁc translational control |
RNA-binding protein | translation initiation | end-to-end complexes
Early vertebrate development is directed by maternally tran-scribed mRNAs (1) that are deadenylated upon their exit
from the nucleus and are stored in a translationally inactive state
(2). During speciﬁc developmental stages, subsets of mRNAs are
readenylated in a highly regulated process known as cytoplasmic
polyadenylation (3, 4) concomitant with their translational acti-
vation. Although they have been best studied during early de-
velopment, dynamic changes in poly(A) tail length also occur in
other cell types. The function of the poly(A) tail in stimulating
translation is mediated by the binding of the cytoplasmic poly(A)-
binding protein (PABP) family of proteins, which are structurally
and functionally distinct from nuclear PABPs (5, 6). Although
vertebrates express multiple cytoplasmic PABPs, which contain a
conserved domain organization, most studies have focused on
the prototypical member PABP1 [also known as PABP, cyto-
plasmic 1 (PABPC1)]. The N terminus of PABP1 contains four
nonidentical RNA recognition motifs (RRMs) which mediate
both RNA and protein interactions. The C terminus comprises
a highly variable proline-rich region that mediates PABP–PABP
interactions important for oligomerization along the poly(A) tail
and the PABP C-terminal domain (PABC) [also known as the
MLLE domain] responsible for several protein–protein inter-
actions (5, 6).
Biochemical studies suggest that metazoan PABP1 stimulates
translation initiation by simultaneously binding the poly(A) tail
and interacting with other translation factors located at the 5′
UTR, including eukaryotic initiation factor (eIF)4G and poly
(A)-binding protein interacting protein 1 (PAIP1) (7–9). These
interactions mediate the circularization of the mRNA, pro-
moting recruitment of the small ribosomal subunit (40S) and
perhaps recycling of translation initiation factors and terminating
ribosomes (10). Furthermore, PABP1 has a largely uncharac-
terized effect on large ribosomal subunit (60S) recruitment and
participates in translation termination via binding to eukaryotic
release factor 3 (eRF3) (5, 6, 11). In addition to this core role
in translation, PABP1 also functions in mRNA turnover and
nonsense-mediated decay (12, 13). Moreover, it is emerging that
PABP1 has a variety of mRNA-speciﬁc roles, including trans-
lational activation and miRNA-mediated repression (5, 14). This
multifunctionality is not fully understood but appears to be
conferred by the ability of PABP1 to interact with key factors.
The other PABPs remain largely uncharacterized, although the
molecular functions of embryonic PABP (ePABP, also known as
ePAB or PABP1-like) have been partially described (15–18).
Given the key role of PABP1 in regulating posttranscriptional
gene expression and its extensive functional characterization, it is
surprising that relatively little is known about the biological roles
of PABP proteins. Deletion of the single poly(A)-binding protein
(PAB1) in Saccharomyces cerevisiae, which serves both nuclear
and cytoplasmic functions, is lethal (19), although in Schizo-
saccharomyces pombe spPABP is not essential (20). In Drosophila
melanogaster, deletion/reduction of dPABP or its deregulated
expression leads to embryonic lethality/male sterility or neuro-
physiological defects, respectively (21, 22). Caenorhabditis elegans
encodes two cytoplasmic PABPs, and mutations in pab-1 cause
defects in the germline and affect longevity (23, 24). However, an
absence of studies precludes any conclusion regarding the es-
sential nature of PABPs in vertebrates.
During Xenopus laevis development, in which the effects of
cytoplasmic polyadenylation have been studied extensively, the
expression patterns of the two identiﬁed PABPs are distinctive:
ePABP protein is abundant during oogenesis and early em-
bryogenesis and is absent later in development. PABP1 protein is
reciprocally expressed, being present at low levels during oogen-
esis and early embryogenesis and gradually increasing after the
resumption of zygotic transcription at the midblastula transition
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(15, 16). This apparent switching of PABPs raises interesting
questions about their respective molecular and/or biological roles
during different developmental stages. Here we address the roles
of PABPs during vertebrate development and explore their func-
tional redundancy. We reveal that morpholino-mediated de-
pletion of PABP1 and ePABP inX. laevis causes severe embryonic
phenotypes and lethality. In contrast, phenotypes resulting from
depletion of the newly identiﬁed PABP4 [also known as inducible
PABP (iPABP) or PABP, cytoplasmic 4 (PABPC4)] are not ob-
served until later in development and comprise mainly anterior
defects. We show that the observed phenotypes are caused, at
least in part, by defects in global protein synthesis and that the
previously uncharacterized PABP4 binds poly(A) and stimulates
translation in a manner similar to PABP1 and ePABP. However,
cross-rescue experiments show that neither PABP4 nor ePABP is
able to rescue the PABP1-deﬁcient phenotype completely, in-
dicating partially differential molecular functions. Taken together
our data demonstrate that although the different members of the
PABP family share a role in global translation, they appear to be
functionally distinct, with multiple regions of PABP contributing
to speciﬁcity.
Results
PABP1 and ePABP Are Essential for X. laevis Development. To ana-
lyze the phenotypic consequences of PABP deﬁciency in verte-
brates, we injected X. laevis embryos with morpholino antisense
oligonucleotides that blocked the translation of speciﬁc PABPs
(Fig. S1). Strikingly, 100% of embryos injected with a PABP1-
speciﬁc morpholino, which depleted PABP1 levels by >90% in
vivo (Fig. 1A), were defective, exhibiting a wide variety of an-
terior and posterior defects (Fig. 1 B and C). Speciﬁc morpho-
logical defects became apparent at stage 25, and all embryos died
by stage 30/31. As is typical of morpholino-mediated knockdown,
a range of phenotypes was observed: Phenotypes at stage 29/30
included abnormal development of eyes, cement gland, tail, and
ﬁn, different degrees of body axis curvature, and defective pos-
terior elongation, with single embryos often having multiple
defects (Fig. 1B and Fig. S2A). In some cases development was
arrested at stage 18–20. The few embryos that appeared mor-
phologically normal had movement defects, because they did not
respond when prodded (Fig. 1C). In contrast, only 10 to 25% of
embryos injected with control morpholino exhibited defects, in-
cluding spina biﬁda and early death, representing nonspeciﬁc
effects. Importantly, injection of another morpholino directed
against a different region of PABP1 mRNA resulted in very
similar phenotypic effects (Fig. S2B). To probe further the
speciﬁcity of the PABP1 phenotypes, a modiﬁed PABP1 mRNA
that could not be recognized by the morpholino (morpholino-
resistant) was injected at different concentrations. In the absence
of morpholino, this mRNA did not cause defects (Fig. S3A).
When coinjected with PABP1 morpholino, it rescued PABP1
protein expression (Fig. 1A) and the morphological and move-
ment defects (Fig. 1 B and C and Fig. S2A), with normal embryos
observed at ∼80% of the frequency seen with control morpho-
lino. Taken together, these data establish that normal vertebrate
embryogenesis depends on PABP1 expression.
Embryos injected with a morpholino that blocks ePABP
translation in vitro and in vivo (Figs. S1B and S4A) showed a
similar range of morphological and movement defects, although
death occurred later, by stage 35. This ﬁnding was perhaps sur-
prising, because ePABP is the predominant PABP in early em-
bryos, but may result from the higher levels of maternal ePABP
(15, 16). ePABP defects were present in both anterior and pos-
terior structures and also were fully penetrant (Fig. 2 A and B
and Fig. S4B). Efﬁcient phenotypic rescue was achieved by
coinjecting a morpholino-resistant ePABP mRNA (Fig. 2 A and
B and Fig. S4B), excluding off-target effects. Embryos injected
with the ePABP mRNA in the absence of morpholino did not
display developmental defects (Fig. S3A). Importantly, an al-
ternative ePABP-speciﬁc morpholino generated similar pheno-
types (Fig. S4C), further showing themorphological andmovement
defects to be speciﬁc. These data provide insight into the biological
role of ePABP, establishing that, like PABP1, it is essential for
vertebrate development.
To gain insight into the mechanism underlying the PABP1 and
ePABP phenotypes, we analyzed the effect of their depletion on
global protein synthesis in embryos. PABP1andePABPmorphants
both showed a signiﬁcant reduction in global protein synthesis, of
40%and25%, respectively (Fig. 2C andD); with the latter perhaps
reﬂecting the higher levels of maternal ePABP (15, 16).
PABP4 Depletion Causes Anterior Defects and Embryonic Lethality.
Bioinformatic analysis identiﬁed a PABP mRNA in X. laevis
encoding a protein that is most closely related to mammalian
PABP4 (Fig. S5 A and B). This newly identiﬁed PABP4 main-
tains the same domain organization as PABP1 (5) and exhibits
high homology to human PABP4 (81% identity) and X. laevis
PABP1 (75% identity). PABP4 mRNA, like PABP1, was de-
tected in a wide variety of adult tissues (Fig. S5C), consistent
with studies in mammals (25). PABP4 mRNA is expressed in
early oocytes, decreases during later oogenesis, and reappears
from stage 7/8 embryos (Fig. S5D) at the onset of zygotic tran-
scription, when ePABP is still the predominant PABP protein.
We investigated the developmental role of this newly identi-
ﬁed PABP by injecting a PABP4-speciﬁc morpholino (Fig. S1C).
Interestingly, morphological defects were observed only after
Fig. 1. PABP1 depletion causes multiple developmental defects and em-
bryonic lethality. (A) Western blot analysis of whole-cell extracts from stage
14–16 embryos injected with control (Ctr) or PABP1-A (PABP1) morpholino
(Mo) ± 10 ng of PABP1 rescue mRNA, using antibodies speciﬁc for PABP1 and
ePABP. (B) Representative photographs of stage 29/30 embryos injected with
control or PABP1-A morpholino ± 10 ng of PABP1 rescue mRNA. PABP1
morphants show abnormal development of anterior (closed arrow) and
posterior (open arrow) structures, spinal curvature (arrowhead), and de-
velopmental arrest at stage 18–20 (asterisk). (Additional photographs are
shown in Fig. S2.) (C) Percentages of control, PABP1 morpholino, and PABP1
rescue embryos (stage 29/30) displaying the indicated phenotypes. Morpho-
logical defects include spinal curvature; abnormal development of eye, ce-
ment gland, tail, and ﬁn; ventral edema; absence of posterior development;
and developmental arrest at stage 18–20. Data represent the average of nine
(PABP1 morpholino) or six (PABP1 rescue) independent experiments, with
∼1,200 or 900 embryos per experimental point, respectively.














stage 29/30, later than in PABP1 and ePABP morphants, and
embryos did not die until stage 50. A number of speciﬁc pheno-
types were observed, but, in sharp contrast to PABP1 and ePABP
morphants, the formation of anterior structures appeared more
sensitive to PABP4 depletion than posterior structures (Fig. 3A).
Frequent defects included cephalic and ventral edema, malfor-
mation of the head, and poor eye development (Fig. 3B). Severe
deformities of the digestive tract also were frequently observed.
In normal stage 41/42 embryos the intestine begins to twist, with
∼360° torsion by stage 44 and 2.5–3.5 revolutions by stage 47.
Many PABP4-deﬁcient embryos failed to exhibit normal in-
testinal coiling (Fig. 3B). Development of the proctodeum was
often impaired or even absent (Fig. 3A). Remarkably, the in-
cidence of morphologically defective embryos was >90% at
stages 47–50 (Fig. 3C), and the embryos also displayed abnormal
swimming motions. Because attempts to generate PABP4-spe-
ciﬁc antibodies proved unsuccessful, we used a FLAG-tagged
morpholino-resistant PABP4 mRNA for rescue experiments at a
dose that did not cause phenotypic defects although the protein
was easily detectable (Fig. S3 B and C). Coinjection of this
mRNA with the PABP4 morpholino efﬁciently rescued the
morphological phenotypes (Fig. 3 A and C), conﬁrming their
speciﬁcity.
In contrast to PABP1 and ePABP, PABP4 depletion appeared
to be associated mainly with anterior defects, leading us to inject
the morpholino into a single presumptive anterior or posterior
cell at the four- to eight-cell stage, targeting only one side of the
embryo. At stage 35–37 PABP4 depletion only caused defects
following injection into an anterior blastomere; 70% of embryos
showed abnormal eye development on the injected side (Fig. 3 D
and F), indicating that formation of anterior structures is more
sensitive to PABP4 depletion. In contrast, ePABP knockdown
caused defective phenotypes after either anterior or posterior
injection (Fig. 3 E and F), consistent with the results shown
in Fig. 2A.
Because PABP4 depletion led to the most distinct phenotypes,
and this vertebrate-speciﬁc PABP remains largely uncharac-
terized, we investigated whether differences in its putative core
function in translation contribute to its developmental require-
ment. To assess PABP4 function in vivo, the polysome proﬁles of
PABP4-deﬁcient embryos were analyzed, revealing a clear re-
duction in polysome peaks compared with control embryos (Fig.
3G), which reﬂects a signiﬁcant decrease in global protein syn-
thesis. Thus, defects in translation appear to be an important
facet of the PABP4 phenotype. Consistent with this result,
PABP4 was found to associate with polysomal as well as non-
polysomal fractions when expressed in oocytes, reminiscent of
ePABP (Fig. S6A). To explore the extent of the mechanistic
similarity between PABP4 and PABP1/ePABP, we directly ex-
amined its quantitative ability to stimulate translation and its
interaction with protein partners. Tethered function analysis in
intact oocytes (9, 17) revealed that PABP4 stimulates the
translation of mRNAs to a level equivalent to PABP1 and
ePABP (Fig. S6 B–D). Moreover, we found that PABP4 binds
poly(A) RNA (Fig S7A) consistent with observations in mam-
mals (25, 26), interacts with translation factors known to be
protein partners of X. laevis PABP1 and ePABP (9, 17, 27), and
engages in PABP–PABP interactions (Fig. S7 C–E), suggesting
that PABP4 may bind mRNAs cooperatively with other PABPs.
Thus, both the ability of PABP4 to stimulate translation and
its mode of action seem to be conserved, revealing that differ-
ences in this core function do not appear to underlie the unique
developmental requirement for this PABP.
PABP1, ePABP, and PABP4 Have Distinct Functions. Conservation of
their core role in translation does not preclude the possibility that
other distinct molecular functions and/or differences in their
temporo-spatial expression contribute to the different phenotypes
associated with PABP1, ePABP, or PABP4 depletion. Thus, cross-
rescue experiments were undertaken with mRNAs containing
identical generic 5′ and 3′ UTRs to negate differences in their
expression. Injection of mRNAs encoding either PABP1-FLAG
or PABP4-FLAG into PABP1morphants resulted in similar levels
of ectopic PABP proteins (Fig. S3C), as expected. PABP1-FLAG
mediated efﬁcient rescue, reducing the PABP1-speciﬁc pheno-
types (morphological and movement) from 91% to 28% of em-
bryos (Fig. 4A and Fig. S8A). PABP4-FLAG expression did not
rescue the speciﬁc phenotypes to the same extent, because they
were reduced only from 91% to 52% (Fig. 4A). Strikingly, cross-
rescue of PABP1 with an ePABP mRNA only reduced the per-
centage of speciﬁc phenotypes from 84% to 42%, whereas PABP1
self-rescue reduced these speciﬁc phenotypes to 16% (Fig. 4B and
Fig. S8B). Thus, these data establish that neither PABP4 nor
ePABP can completely substitute for PABP1 during development,
providing evidence that metazoan members of this family have
nonredundant as well as overlapping molecular functions.
Multiple Determinants Underlie PABP Speciﬁcity. Our data reveal
the existence of functional differences between PABP family
members (Fig. 4), which are not linked to their function in global
translation (Figs. 2 C and D and 3G and Figs. S6 and S7). The C-
terminal region is the most diverse among PABPs, leading us to
hypothesize that it may be responsible for these differences. To
address this hypothesis, domain-swap experiments were un-
dertaken between the RRM and C-terminal regions of PABP1
Fig. 2. ePABP is essential for development. (A) Representative photographs
of stage 30–32 embryos injected with control or ePABP-A (ePABP) morpho-
lino ± 10 ng of ePABP rescue mRNA. (Additional photographs are shown in
Fig. S4.) (B) Percentages of control, ePABP morpholino, and ePABP rescue
embryos (stage 30–32) displaying the indicated phenotypes. Legend is as in
Fig. 1C. Data represent the average of seven (ePABP morpholino) or three
(ePABP rescue) independent experiments, with ∼900 or 300 embryos per
experimental point, respectively. Control and (C) PABP1 or (D) ePABP mor-
phants were labeled metabolically with [35S]methionine, and newly syn-
thesized proteins were TCA precipitated. Data are shown as percentage of
[35S]methionine incorporation relative to control (set to 100%) and repre-
sent the average of two independent experiments, with ∼60 embryos per
experimental point. Error bars indicate SEM. *P < 0.05 and **P < 0.01 versus
control. P values were determined by t test.
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and ePABP, which share 83% and 56% identity, respectively.
First, the C terminus of PABP1 was appended to the RRM re-
gion of ePABP (eRRM/1Ct) and was coinjected with the PABP1
morpholino. Interestingly, rescue with eRRM/1Ct reduced
PABP1-speciﬁc phenotypes from 89% to 28%, compared with
a reduction from 89% to 43% with wild-type ePABP (Fig. 5A),
showing that substitution of the PABP1 C terminus results in
a more efﬁcient rescue. However, this rescue was less efﬁcient
than wild-type PABP1, although Western blotting showed that
the hybrid protein was expressed similarly in embryos (Fig. 5B).
Importantly, the reciprocal rescue of PABP1 phenotypes using
a construct in which the ePABP C terminus was appended to the
RRMs of PABP1 (1RRM/eCt), also gave an intermediate level
of cross rescue (Fig. 5 C and D). Thus, our data reveal that
multiple regions underlie the unique requirement for PABP1.
Discussion
By providing phenotypic studies of PABPs in vertebrate de-
velopment, we have uncovered essential but distinct functional
roles for all three members of the X. laevis PABP family. These
results signiﬁcantly extend the previous analysis of PABP1 in
yeast and invertebrates (19–24). In each case, developmental
defects were accompanied by a signiﬁcant loss of protein syn-
thesis, establishing the role of metazoan PABPs in protein syn-
thesis in vivo and showing that a decrease in overall translation
contributes to the phenotypes. However, given the pleiotropic
nature of PABP1, it is likely that defects in other aspects of
posttranscriptional regulation (5, 12–14) also contribute to the
phenotypes. Interestingly, injection of PABP mRNAs in non-
depleted embryos did not result in phenotypic consequences, sug-
gesting that overexpression is tolerated.
Altered PABP levels or differences in their temporo-spatial
expression may contribute to the observed phenotypes. However,
cross-rescue experiments revealed that neither PABP4 nor
ePABP, even when similarly expressed, can substitute completely
for PABP1, because the percentage of defective phenotypes ob-
tained is approximately two and three times greater, respectively,
than with the PABP1 self-rescue. These results strongly indicate
Fig. 3. PABP4 depletion causes anterior defects and embryonic lethality. (A) Representative photographs of stage 45–47 embryos injected with control or
PABP4 morpholino ± 1 ng of PABP4-FLAG rescue mRNA. Arrows indicate abnormal or absent proctodeum. (B) Control (stage 45/46) and PABP4 morphants,
which show ventral and cephalic edema (large arrowhead), absence of eye (small arrowhead), and reduced intestinal torsion (arrow). (C) Percentages of
control, PABP4 morpholino, and PABP4 rescue embryos (stage 47–50) displaying the indicated phenotypes. Morphological defects include ventral and cephalic
edema, abnormal head and eye development, and digestive tract defects. Data represent the average of three independent experiments, with ∼400 embryos
per experimental point. (D and E) Representative photographs of stage 35–37 control embryos and embryos injected anteriorly (Ant) or posteriorly (Post) with
(D) PABP4 or (E) ePABP-A (ePABP) morpholino. Arrowheads indicate abnormal head/eye development; and arrows indicate abnormal posterior development.
(F) Percentages of control, PABP4, and ePABP-A morpholino embryos from D and E displaying the indicated phenotypes. Data represent the average of ﬁve
(PABP4) or three (ePABP) independent experiments, with ∼120 or 90 embryos, respectively, per experimental point. (G) Polysomal proﬁling of stage 40–42
control and PABP4 morphants over a 10–50% sucrose gradient with a 60% cushion. A representative experiment is shown, and the positions of the 80S
ribosome and polysomes are indicated.














that differential molecular functions also must contribute to the
requirement for multiple PABPs during development, which is
intriguing, given the high degree of amino acid similarity, espe-
cially between PABP1 and PABP4. Thus, our results identify the
existence of biologically relevant differences between the func-
tions of individual PABP family members in metazoa.
Importantly, mechanistic analysis of PABP function provides
insight into the basis of these differences. We establish that
PABP1, ePABP, and PABP4 each has an important role in de-
termining overall translation rates in vivo, and SDS/PAGE
analysis of [35S]methionine-labeled extracts from embryos suggest
that synthesis of a wide range of proteins is affected (Fig. S9),
conﬁrming an effect on global translation. These global defects
are consistent with our ﬁnding that PABP4 can bind poly(A) and
stimulate translation similarly to PABP1 and ePABP, sharing
interactions with basal translation factors. The evolutionary
conservation of PABP4 suggests that this ability may be main-
tained in other species. Thus, all three PABPs appear to play
indistinguishable rather than distinct roles in global translation,
excluding this as a mechanism to explain the speciﬁcity. This
situation differs from the eIF4A family in which one member
(eIF4AIII) appears to have an alternative function in post-
transcriptional regulation (28, 29).
Since their ability to promote global translation does not vary
signiﬁcantly, their distinct functions must be related to other
aspects of posttranscriptional control in which their roles are less
well characterized. Cross-rescue experiments swapping the less
conserved C-terminal region of PABP1 and ePABP, although
unable to formally exclude subtle or cell type-speciﬁc differences
in PABP stability, revealed that multiple regions contribute to
PABP speciﬁcity. Because the C-terminal region mediates inter-
actions with proteins but not with RNA (Fig. S10A), our results
strongly suggest that PABP-speciﬁc protein interactions with
partners other than basal translation factors (which interact with
all three) play a role in the requirement for individual PABPs. The
high conservation of the PABC domain suggests that differential
protein interactions may be mediated by the proline-rich region,
which is highly variable and predicted to be alternatively spliced
in mammals, providing great scope for PABP-speciﬁc protein–
protein interactions. It is tempting to speculate that PABP-speciﬁc
protein partners may be involved in mRNA-speciﬁc regulation, as
misregulation of even a single essential mRNA could be sufﬁcient
to cause lethality. In this regard it is interesting to note that
translational activation by mRNA-speciﬁc binding proteins that
directly recruit PABP through C-terminal interactions has been
described in X. laevis (30). However, the few characterized
interactions mediated by this region do not appear to be PABP
speciﬁc (Fig. S10 A and C); thus exhaustive identiﬁcation of the
PABP interactome is required.
Our data also, surprisingly, show that the relatively conserved
RRM1–4 region is important for PABP speciﬁcity. This region
interacts with both proteins and RNA, including, in other spe-
cies, proteins that are involved in mRNA-speciﬁc regulation
(31–33). Any differential RNA binding probably involves ele-
ments other than the poly(A) tail, because each of the PABPs
binds poly(A) efﬁciently (Fig. S7 A and B). Thus, poly(A)-
independent recruitment of individual PABPs to speciﬁc
mRNAs, via RNA or proteins, may provide additional mecha-
nisms for regulating mRNAs that are stored during development
with short poly(A) tails.
In conclusion, our investigation provides insight into the dis-
tinct roles of vertebrate PABPs and in so doing argues against
the hypothesis that members of this family are functionally re-
dundant. These unexpected differences provide an explanation
for developmental switching between PABPs (15, 16) and the
presence of multiple PABPs within many mammalian cell types
(34) and emphasize the importance of dissecting the roles of
individual family members in whole organisms. The approach
Fig. 4. PABP4 and ePABP cannot rescue PABP1-depleted embryos efﬁ-
ciently. Embryos were injected with control or PABP1-A (PABP1) morpholino ±
(A) 1 ng of PABP1-FLAG or PABP4-FLAG rescue mRNA or (B) 10 ng of PABP1
or ePABP rescue mRNA. Percentages of stage 29/30 embryos displaying the
indicated phenotypes are shown; numbers indicate the percentage of
PABP1-speciﬁc phenotypes in each case (morphological plus movement
defects). Data represent the average of approximately (A) 350 embryos or
(B) 500 embryos per experimental point, in three or four independent
experiments, respectively. ***P < 0.0001, as determined by Fisher’s exact
test. (Photographs are shown in Fig. S8.)
Fig. 5. Multiple regions of PABP1 determine speciﬁcity. Embryos were
injected with control or PABP1-A (PABP1) morpholino ± 10 ng of PABP1,
ePABP, or either (A) eRRM/1Ct or (C) 1RRM/eCt rescue mRNA. Percentages of
stage 26–31 embryos displaying the indicated phenotypes are given. Numbers
indicate the percentage of PABP1-speciﬁc phenotypes in each case (morpho-
logical plus movement defects). Data represent the average of approximately
(A) 160 embryos or (C) 135 embryos per experimental point, in four or three
independent experiments, respectively. ***P < 0.0001, as determined by
Fisher’s exact test. (B and D) Western blots of embryos from A and C using an
anti-PABP1 antibody, which does not recognize 1RRMs/eCt (1/e) because it is
raised against a C-terminal PABP1 peptide. 1, PABP1; e, ePABP; e/1, eRRM/1Ct.
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described here provides a powerful in vivo tool for future work
aimed at understanding the challenging and intriguing issues of
PABP function and speciﬁcity.
Methods
Plasmid construction and supporting procedures are described in SI Methods.
Animal experiments were performed under license and in accordance with
the Animals in Scientiﬁc Procedures Act (1986).
The following translation-blocking morpholino antisense oligonucleo-
tides, modiﬁed with 3′ carboxyﬂuorescein, were used (Gene Tools): PABP1-A:
(5′ UTR) CTTCACTCTT CTCTTTACC GGATTT; PABP1-B: (AUG) GGTAGCTGG
GAGCACTGGG ATTCAT; ePABP-A: (5′ UTR) GGATTCGCCC TCAGCCTGAT
AACTC; ePABP-B: (AUG) CGGCTCCGGT TGCATTCATG TTTGC; PABP4: (5′ UTR)
CACTGAGCAA TAATGGGACG GCTAA; Control: CCTCTTACCT CAGTTACA-
ATT TATA.
Approximately 7 fmoles of morpholino and/or 1–10 ng of in vitro tran-
scribed, capped, and polyadenylated mRNA were injected into both blas-
tomeres in X. laevis embryos at the two-cell stage. Injections into single
anterior or posterior blastomeres were performed with 3 fmoles of mor-
pholino at the four- to eight-cell stage. Injected embryos were selected by
ﬂuorescence and allowed to progress for phenotypic analysis. Embryos were
staged according to Nieuwkoop and Faber (35). For photography, embryos
were ﬁxed in 0.1 M 3-(N-Morpholino)propanesulfonic acid (pH 7.4), 2 mM
EGTA, 1 mM MgSO4, and 3.7% formaldehyde and were washed and stored
in 100% ethanol.
Western Blot Analysis. Embryos were homogenized mechanically in TE buffer
(10 mM Tris-HCl, pH 8, 1 mM EDTA, pH 8). One embryo per lane was sep-
arated by SDS-PAGE, transferred to PVDFmembranes (Millipore), and probed
with mouse monoclonal anti-PABP1 10E10 (1:2,000; Abcam), anti-FLAG M2
(1:6,000; Sigma), rabbit anti-PABP1 (1:500) (15), or anti-ePABP (1:2,000) (17).
HRP-conjugated anti-mouse (Pierce Biotechnology) and anti-rabbit (Sigma)
IgGs were used as secondary antibodies, and signals were detected by en-
hanced chemiluminescence (GE Healthcare).
Metabolic Labeling. Embryos were coinjected with morpholino, as above, and
with 35 nCi of [35S]methionine. Embryos were collected at stage 14–16,
pooled into groups of ﬁve, and homogenized in TE. Trichloroacetic acid
(TCA) precipitates (10%) were counted by liquid scintillation to determine
[35S]methionine incorporation.
Sucrose Gradient Analysis. Eighty stage VI oocytes or 30 stage 40–42 embryos
were mechanically lysed in basic lysis buffer (300 mM KCl, 10 mM MgCl2, 20
mM Tris-HCl, pH 7.4) supplemented with 0.5% sodium deoxycholate and 150
μg/mL cycloheximide or 20 mM EDTA. Cleared supernatants were layered
onto a 10–50% sucrose gradient over a 60% cushion in basic lysis buffer
and centrifuged for 2 h at 247,000 × g (38,000 rpm) using a TH-641 rotor
(Sorvall). Fractions were collected using a density gradient fractionation
system (Teledyne Isco). Proteins were extracted from fractions by 10% TCA
precipitation before Western analysis.
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